Mark Danta1, Alison J Rodger. 1. St Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia. m.danta@unsw.edu.au
Abstract
PURPOSE OF REVIEW: The epidemiology of hepatitis C virus (HCV) in HIV has changed significantly over the past decade. This review will outline the current epidemiology of HCV in HIV infection, focusing on the recent changes and factors which have been related to the increase in HCV transmission in HIV-infected men who have sex with men (MSM). RECENT FINDINGS: Since 2000 there has been recognition in the postindustrialized world that there has been a dramatic rise in the incidence of HCV in HIV-infected MSM. Whereas sexual transmission of HCV remains controversial in the general population, there is increasing evidence that permucosal (sexual and mucosally administered drugs) rather than parenteral risks have become key factors in HCV transmission in HIV-infected MSM. At the most basic level, transmission depends on disruption of a barrier and exposure to infected fluids, usually blood. Whereas transmission factors are often closely entwined, they can be characterized as behavioural and biological factors. SUMMARY: With an improved understanding of the epidemiology of HCV in this population, interventions by relevant health authorities could be better focused.
PURPOSE OF REVIEW: The epidemiology of hepatitis C virus (HCV) in HIV has changed significantly over the past decade. This review will outline the current epidemiology of HCV in HIV infection, focusing on the recent changes and factors which have been related to the increase in HCV transmission in HIV-infectedmen who have sex with men (MSM). RECENT FINDINGS: Since 2000 there has been recognition in the postindustrialized world that there has been a dramatic rise in the incidence of HCV in HIV-infected MSM. Whereas sexual transmission of HCV remains controversial in the general population, there is increasing evidence that permucosal (sexual and mucosally administered drugs) rather than parenteral risks have become key factors in HCV transmission in HIV-infected MSM. At the most basic level, transmission depends on disruption of a barrier and exposure to infected fluids, usually blood. Whereas transmission factors are often closely entwined, they can be characterized as behavioural and biological factors. SUMMARY: With an improved understanding of the epidemiology of HCV in this population, interventions by relevant health authorities could be better focused.
Authors: Jason Grebely; Margaret Hellard; Tanya Applegate; Kathy Petoumenos; Barbara Yeung; Jordan J Feld; William Rawlinson; Andrew R Lloyd; Jacob George; John M Kaldor; Gregory J Dore; Gail V Matthews Journal: AIDS Date: 2012-08-24 Impact factor: 4.177
Authors: Sofia R Bartlett; Brendan Jacka; Rowena A Bull; Fabio Luciani; Gail V Matthews; Francois M J Lamoury; Margaret E Hellard; Behzad Hajarizadeh; Suzy Teutsch; Bethany White; Lisa Maher; Gregory J Dore; Andrew R Lloyd; Jason Grebely; Tanya L Applegate Journal: Infect Genet Evol Date: 2015-11-26 Impact factor: 3.342
Authors: Axel J Schmidt; Luis Falcato; Benedikt Zahno; Andrea Burri; Stephan Regenass; Beat Müllhaupt; Philip Bruggmann Journal: BMC Public Health Date: 2014-01-06 Impact factor: 3.295
Authors: César Garriga; Sandra Manzanares-Laya; Patricia García de Olalla; Pilar Gorrindo; Sabela Lens; Ricard Solà; María Martínez-Rebollar; Montserrat Laguno; Jordi Navarro; Xavier Torras; Mercè Gurguí; María-Jesús Barberá; Josep Quer; Eva Masdeu; Pere Simón; Miriam Ros; Anna de Andrés; Joan A Caylà Journal: PLoS One Date: 2017-11-14 Impact factor: 3.240
Authors: Andy Guise; T Charles Witzel; Sema Mandal; Caroline Sabin; Tim Rhodes; Anthony Nardone; Magdalena Harris Journal: BMC Infect Dis Date: 2018-06-19 Impact factor: 3.090
Authors: Abbas Alipour; Abbas Rezaianzadeh; Jafar Hasanzadeh; Abdorreza Rajaeefard; Mohammad Ali Davarpanah Journal: Hepat Mon Date: 2013-11-05 Impact factor: 0.660